Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Dow Inc    DOW.WI


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

DOW INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
02/25/2020 | 05:25pm EDT

Item 7.01. Regulation FD Disclosure.

On February 25, 2020, The Dow Chemical Company (the "Company"), a wholly owned subsidiary of Dow Inc., issued a press release announcing the closing of its notes offering described below and the use of proceeds to fund the full redemption of its 3.000% Notes due November 15, 2022 and to repay other indebtedness. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information included in this Current Report on Form 8-K under this Item 7.01 (including Exhibit 99.1) shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 8.01. Other Events.

On February 25, 2020, the Company completed the offering of €2.250 billion in aggregate principal amount of notes, consisting of €1,000,000,000 aggregate principal amount of 0.500% Notes due 2027 (the "2027 Notes"), €750,000,000 aggregate principal amount of 1.125% Notes due 2032 (the "2032 Notes") and €500,000,000 aggregate principal amount of 1.875% Notes due 2040 (the "2040 Notes," and together with the 2027 Notes and the 2032 Notes, the "Notes"). The Notes were issued pursuant to the Company's registration statement on Form S-3 (File No. 333-232862-01), filed with the Securities and Exchange Commission on July 26, 2019 (the "Registration Statement").

In connection with the offering of the Notes, the Company is filing a copy of the Underwriting Agreement, among the Company and the several underwriters named therein, attached as Exhibit 1.1 to this Current Report on Form 8-K and incorporated herein by reference and into the Registration Statement.

The Notes were issued under an Indenture dated as of July 26, 2019 (the "Indenture"), among the Company, Dow Inc., as a party with respect to the sections described therein, and The Bank of New York Mellon Trust Company, N.A., as trustee. The Indenture and form of the 2027 Notes, 2032 Notes and 2040 Notes are attached as Exhibits 4.1, 4.2, 4.3 and 4.4, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

In connection with the offering of the Notes, the Company is filing a legal opinion by counsel regarding the validity of the Notes, attached as Exhibit 5.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits


  1.1*        Underwriting Agreement, dated as of February 18, 2020, among The Dow
            Chemical Company and the several underwriters named therein.
  4.1         Indenture dated as of July 26, 2019, between The Dow Chemical
            Company, Dow Inc. and The Bank of New York Mellon Trust Company, N.A.,
            as trustee (filed as Exhibit 4.3 to the Company's Annual Report on
            Form 10-K, filed on February 7, 2020 and incorporated herein by
  4.2*        Form of 0.500% Notes due 2027
  4.3*        Form of 1.125% Notes due 2032
  4.4*        Form of 1.875% Notes due 2040
  5.1*        Opinion dated February 25, 2020 of Shearman & Sterling LLP.
  23.1*       Consent of Shearman & Sterling LLP (included in Exhibit 5.1).
  99.1*       Press Release issued by The Dow Chemical Company, dated February 25,
104         Cover Page Interactive Data File (embedded within the Inline XBRL

* Documents filed or furnished with this report.

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on DOW INC
08:33aDow - First license of more sustainable isononyl alcohol production process t..
05/28DOW : launches new post-consumer recycled plastic resin in Asia Pacific
05/28DOW : New generation food contact silicone emulsion by Dow combines productivity..
05/28DOW : moves ahead with the RENUVA Mattress Recycling Program; Pioneering product..
05/26DOW : to participate in Bernstein's 36th Annual Strategic Decisions Conference
05/26UPM, Dow Launch New Bioplastic Film
05/22DOW : Announces $1 Million in Disaster Relief Funding for Flood Recovery
05/18DOW : collaborates with multiple partners to develop and donate Level 2 medical ..
05/15DOW : Virtual Goldman Sachs Industrials & Materials Conference Transcript
05/14Whirlpool, Dow, Reynolds Making Respirators for Healthcare Workers
More news
Financials (USD)
Sales 2020 35 822 M - -
Net income 2020 832 M - -
Net Debt 2020 13 370 M - -
P/E ratio 2020 39,5x
Yield 2020 7,04%
Capitalization 30 074 M 30 074 M -
EV / Sales 2019
EV / Sales 2020 1,21x
Nbr of Employees 36 500
Free-Float 98,2%
Duration : Period :
Dow Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 21
Average target price 38,05 $
Last Close Price 40,60 $
Spread / Highest target 18,2%
Spread / Average Target -6,27%
Spread / Lowest Target -23,6%
EPS Revisions
James R. Fitterling Chairman & Chief Executive Officer
Howard I. Ungerleider President & Chief Financial Officer
Peter Holicki Senior VP-Operations, Manufacturing & Engineering
Attiganal N. Sreeram Chief Technology Officer & Senior Vice President
Melanie Kalmar VP, Chief Information & Digital Officer
Sector and Competitors
1st jan.Capitalization (M$)
DOW INC0.00%28 600
LG CHEM, LTD.24.41%23 408
COVESTRO AG-19.69%6 774